Use of 5-Thia-1,4-diazabicyclo [4.2.0] octane-3,8-dioxo compounds in antitumor therapy
    2.
    发明公开
    Use of 5-Thia-1,4-diazabicyclo [4.2.0] octane-3,8-dioxo compounds in antitumor therapy 失效
    Verdendung von 5-Thia-1,4-Diazabicyclo [4.2.0] Octane-3,8-dioxo Verbindungen in der Antitumor-Therapie

    公开(公告)号:EP0705606A1

    公开(公告)日:1996-04-10

    申请号:EP95114673.7

    申请日:1995-09-18

    IPC分类号: A61K31/54

    CPC分类号: A61K31/549

    摘要: The present invention relates to the use of 5-thia-1,4-diazabicyclo[4.2.0]octane-3,8-dioxo compounds of the general formula I,

    wherein the radicals have the following meanings:

    R¹ is hydrogen, halogen,
    R² is hydrogen, halogen, amino, PhCH₂CONH, PhOCH₂CONH, phthalimido, o-MeNHCOC₆H₄CONH, 3-o-chlorophenyl-5-methyl-isoxazolyl-4-carbonyl amino,
    R³ is hydrogen, alkyl, benzyl, a heterocyclic ring e.g. isoxazole, pyrazole,
    n is 1 or 2.

    In the application examples of the suppression of uterine cervix carcinoma cells (HeLa) by the use of various substituted 5-thia-1,4-diazabicyclo[4.2.0]octane-3,8-dioxo derivatives are disclosed.

    摘要翻译: 本发明涉及通式I的“5-硫杂-1,4-二氮杂双环[2,4.2,0]辛烷-3,8-二氧代化合物的用途,其中基团具有以下含义:R 1是氢 卤素,R 2是氢,卤素,氨基,PhCH 2 CONH,PhOCH 2 CONH,苯二甲酰亚氨基,o-MeNHCOC 6 H 4 CONH,3-邻氯苯基-5-甲基 - 异恶唑基-4-羰基氨基,R 3是氢,烷基, 苄基,杂环例如 异恶唑,吡唑,n为1或2.在通过使用各种取代的5-硫杂-1,4-二氮杂双环[2,4.2,0]辛烷-3,8-二氧代衍生物抑制子宫颈癌细胞(HeLa)的应用实施例中 被披露。